ADVM Adverum Biotechnologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ADVM

Price (delayed)

$9.01

Market cap

$881.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.38

Enterprise value

$843.96M

Sector: Healthcare
Industry: Biotechnology
Website: https://adverum.com/

Highlights

Adverum Biotechnologies's debt has decreased by 7% YoY
Adverum Biotechnologies's equity has surged by 148% YoY but it has decreased by 7% QoQ
The quick ratio has soared by 140% YoY but it has contracted by 27% from the previous quarter
ADVM's gross profit has shrunk by 100% YoY
ADVM's revenue has dropped by 100% year-on-year

Key stats

What are the main financial stats of ADVM
Market
Shares outstanding
97.8M
Market cap
$881.14M
Enterprise value
$843.96M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.02
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$116.39M
EBITDA
-$112.24M
Free cash flow
-$91.14M
Per share
EPS
-$1.38
Free cash flow per share
-$1.07
Book value per share
$4.46
Revenue per share
$0
TBVPS
$5.67
Balance sheet
Total assets
$482.57M
Total liabilities
$48.22M
Debt
$26.24M
Equity
$434.35M
Working capital
$413.57M
Liquidity
Debt to equity
0.06
Current ratio
20.82
Quick ratio
20.64
Net debt/EBITDA
0.33
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-28.1%
Return on equity
-31.6%
Return on invested capital
-33.1%
Return on capital employed
-25.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADVM stock price

How has the Adverum Biotechnologies stock price performed over time
Intraday
1.69%
1 week
-0.66%
1 month
-17.57%
1 year
-30.21%
YTD
-16.88%
QTD
-8.62%

Financial performance

How have Adverum Biotechnologies's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$117.95M
Net income
-$117.51M
Gross margin
N/A
Net margin
N/A
ADVM's gross profit has shrunk by 100% YoY
ADVM's revenue has dropped by 100% year-on-year
Adverum Biotechnologies's net income has shrunk by 82% YoY and by 19% QoQ
ADVM's operating income has plunged by 72% YoY and by 17% from the previous quarter

Growth

What is Adverum Biotechnologies's growth rate over time

Valuation

What is Adverum Biotechnologies stock price valuation
P/E
N/A
P/B
2.02
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ADVM's EPS is down by 37% YoY and by 8% QoQ
Adverum Biotechnologies's equity has surged by 148% YoY but it has decreased by 7% QoQ
The price to book (P/B) is 38% lower than the last 4 quarters average of 3.2 but 4.7% higher than the 5-year quarterly average of 1.9
ADVM's revenue has dropped by 100% year-on-year

Efficiency

How efficient is Adverum Biotechnologies business performance
Adverum Biotechnologies's return on invested capital has increased by 34% YoY and by 4.1% QoQ
Adverum Biotechnologies's return on equity has increased by 14% YoY
The company's return on assets rose by 6% YoY

Dividends

What is ADVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADVM.

Financial health

How did Adverum Biotechnologies financials performed over time
The quick ratio has soared by 140% YoY but it has contracted by 27% from the previous quarter
ADVM's current ratio has surged by 130% year-on-year but it is down by 27% since the previous quarter
Adverum Biotechnologies's debt is 94% lower than its equity
Adverum Biotechnologies's equity has surged by 148% YoY but it has decreased by 7% QoQ
Adverum Biotechnologies's debt to equity has shrunk by 63% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.